Home > No evidence Pfizer vaccine won't work against new strain: EMA chief

News
No evidence Pfizer vaccine won't work against new strain: EMA chief

Description

The head of the EU's medicines regulator says there is no evidence that the Pfizer-BioNTech vaccine wouldn't protect against a new strain of the coronavirus found mainly in Britain. SOUNDBITE

Added on the 21/12/2020 16:06:18 - Copyright : AFPTV - First images

To customise your video :

Or Create an account

More videos on the subject

  • EU regulator approves Pfizer-BioNTech vaccine: EMA chief

    The Head of EMA Communication Department Marie-Agnes Heine announces that the Human Medicines Committee has "recommended a conditionnal marketing authorisation for the first Covid-19 vaccine for the EU market". SOUNDBITE

    21/12/2020 - AFPTV - First images
  • EU chief says Pfizer guarantees all promised vaccine doses

    European Commission chief Ursula von der Leyen says Pfizer guarantees all promised vaccine doses for the first quarter after six EU states voiced "severe concern" over delays. SOUNDBITE

    15/01/2021 - AFPTV - First images
  • EU 'to authorise a contract for up to 300 million doses' BioNTech/Pfizer vaccine: chief

    The President of the European Commission Ursula von der Leyen announces that the EU will "authorise a contract for up to 300 million doses of the vaccine developed by BioNTech and Pfizer", in a video published on the Commission's Twitter account. SOUNDBITE

    10/11/2020 - AFPTV - First images
  • NATO chief Stoltenberg hails work done at Madrid summit

    At a press conference on the last day of the NATO summit in Madrid, alliance chief Jens Stoltenberg hails the work done over the course of the summit, which includes agreements on Finland and Sweden's membership, support for Ukraine, and work on the global food crisis. The alliance is seeking to overhaul its defences in response to Russia's invasion of Ukraine. SOUNDBITE

    30/06/2022 - AFPTV - First images
  • US panel recommends Pfizer Covid vaccine in 5-to-11s

    A medical panel of US government advisors votes to recommend authorizing the Pfizer Covid-19 vaccine for five-to-11-year-olds, paving the way for younger children to get their shots within weeks. Seventeen of the independent experts convened by the Food and Drug Administration (FDA) voted in favor and one abstained. IMAGES

    26/10/2021 - AFPTV - First images

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32